Evidence map›Paper›PMID 31513554›Full record

ArticleJournal of acquired immune deficiency syndromes (1999)2019

Marijuana Use and Its Associations With Pain, Opioid Dose, and HIV Viral Suppression Among Persons Living With HIV on Chronic Opioid Therapy.

Jessica S Merlin, Jeffrey H Samet, Debbie M Cheng, Marlene C Lira, Judith I Tsui, Leah S Forman, Jonathan Colasanti, Alexander Y Walley, Carlos Del Rio, Jane M Liebschutz

Open access · greenAbstract read
In one paragraph

Article in Journal of acquired immune deficiency syndromes (1999), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. The impact of cannabinoids on inflammasome signaling in HIV-1 infection.NeuroImmune pharmacology and therapeutics · 2023
    Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

Jessica S MerlinDivision of General Internal Medicine, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA.
Jeffrey H SametClinical Addiction Research and Education Unit, Section of General Internal Medicine, Department of Medicine, Boston Medical Center, Boston, MA.
Debbie M ChengDepartment of Biostatistics, Boston University School of Public Health, Boston, MA.
Marlene C LiraClinical Addiction Research and Education Unit, Section of General Internal Medicine, Department of Medicine, Boston Medical Center, Boston, MA.
Judith I TsuiSection of General Internal Medicine, Department of Medicine, University of Washington and Harborview Medical Center, Seattle, WA.
Leah S FormanBiostatistics and Epidemiology Data Analytics Center (BEDAC), Boston University School of Public Health, Boston, MA.
Jonathan ColasantiDivision of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, GA.
Alexander Y WalleyClinical Addiction Research and Education Unit, Section of General Internal Medicine, Department of Medicine, Boston Medical Center, Boston, MA.
Carlos Del RioDivision of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, GA.
Jane M LiebschutzDivision of General Internal Medicine, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA.
Boston University · USBoston Medical Center · USEmory University · USUniversity of Pittsburgh · USUniversity of Washington · US

Funding

Virology and Molecular Biomarkers CoreP30AI050409 · NIAID · EMORY UNIVERSITY · PI Ann M Chahroudi, Colleen F Kelley · 2002 to 2026
$74.0M
Translational ScienceP30AI042853 · NIAID · MIRIAM HOSPITAL · PI CURT G BECKWITH · 1998 to 2026
$51.7M
Improving Physician Opioid Prescribing for Chronic Pain in HIV-infected PersonsR01DA037768 · NIDA · BOSTON MEDICAL CENTER · PI DEL RIO, CARLOS, SAMET, JEFFREY H. · 2014 to 2018
$5.3M
Evaluation of the efficacy and mechanisms of a novel intervention for chronic pain tailored to people living with HIVR01MH115754 · NIMH · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI MERLIN, JESSICA S · 2018 to 2022
$3.1M
Prescription opioid use, misuse, disorders and HIV outcomesR01DA039046 · NIDA · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI STARRELS, JOANNA L. · 2015 to 2018
$2.4M
Reducing HIV risk behavior in depressed and non-depressed older adults with HIVR01AG053081 · NIA · OREGON HEALTH & SCIENCE UNIVERSITY · PI LOVEJOY, TRAVIS IAN · 2016 to 2019
$2.1M
Adherence Intervention for HIV-infected Drug UsersK23DA039037 · NIDA · UNIVERSITY OF TEXAS AT AUSTIN · PI CLABORN, KASEY R · 2015 to 2019
$919k
Development of a Behavioral Intervention for Chronic Pain in Individuals with HIVK23MH104073 · NIMH · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI MERLIN, JESSICA S · 2015 to 2018
$732k
Non-Medical Use of Prescription Opioids Among HIV-Infected Individuals: Trajectories and Impact on Health OutcomesR01DA040471 · NIDA · YALE UNIVERSITY · PI EDELMAN, E. JENNIFER · 2016 to 2018
$716k
NIAID NIH HHS P30 AI042853NIAID NIH HHS P30 AI050409NIA NIH HHS R01 AG053081NIDA NIH HHS K23 DA039037NIDA NIH HHS R01 DA037768NIDA NIH HHS R01 DA039046NIDA NIH HHS R01 DA040471NIMH NIH HHS K23 MH104073NIMH NIH HHS R01 MH115754
6 · The paper itself

Abstract

backgroundMedical marijuana is legal in 29 US states and the District of Columbia: both HIV and chronic pain are "approved conditions" for receipt. Chronic pain is common among people living with HIV (PLWH). We anticipate PLWH will question their providers about medical marijuana for chronic pain. We examined marijuana use and its associations with pain, opioid dose, and HIV viral suppression among PLWH receiving chronic opioid therapy.

methodsPLWH prescribed chronic opioid therapy were recruited into the Targeting Effective Analgesia in Clinics for HIV cohort. The main exposure variable was any past 12-month marijuana use. The primary outcomes were (1) opioid misuse (≥9 on the Current Opioid Misuse Measure) and (2) opioid dose (morphine equivalent daily dose). HIV viral load (VL) suppression (<200 copies/μL) and pain severity and interference using the Brief Pain Inventory were exploratory outcomes.

resultsParticipants (n = 166) were men (65%), Black (72%), and had an undetectable VL (89%). We found no significant association between current marijuana use and opioid misuse, opioid dose, or pain. Current marijuana use was associated with 3.03 times the odds of having a detectable VL (95% odds ratio: 1.11-8.31, P = 0.03) while controlling for depressive symptoms and other substance use. DISCUSSION: We did not detect an association between marijuana use and opioid misuse behaviors, opioid dose, or pain. In an exploratory analysis, current marijuana use was associated with 3× greater odds of having a detectable VL. This study provides insights into potential consequences of marijuana use among PLWH with chronic pain.

Indexed as

Marijuana UseAdultAgedAnalgesics, OpioidChronic PainCross-Sectional StudiesFemaleHIV InfectionsHumansMaleMiddle AgedViral LoadAnalgesics, Opioid

Identifiers

PMID31513554
PMCPMC6746234
OpenAlexW2950275529

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.